PMGC Holdings Inc. ELAB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-11-21
PMGC Holdings Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 31.4% | — | 66.2% | 58.4% |
| Net margin | -1313.0% | — | -251.2% | -234.9% |
| FCF margin | -1080.5% | — | -266.7% | — |
| Return on assets | -60.2% | -69.4% | -82.9% | -95.1% |
| Return on equity | -98.9% | -93.8% | -112.4% | -159.1% |
| Current ratio | 1.74 | 3.36 | 3.79 | 2.64 |
| Revenue growth | — | — | 123.5% | — |
Source: SEC EDGAR filings · CIK 0001840563 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.